A best evidence topic in cardiovascular surgery was written according to a structured protocol. The question addressed was whether patients with severe asymptomatic carotid and coronary artery diseases should undergo simultaneous carotid endarterectomy (CEA) and coronary artery bypass grafting (CABG). A total of 624 papers were found using the reported search, of which 20 represent the best evidence to answer the clinical question. The author, journal, date and country of publication, patient group studied, study type, relevant outcomes, results and study results of these papers are tabulated. Previous cohort studies showed mixed results, while advocating for the necessity of a randomized controlled trial (RCT). A recent RCT showed that patients undergoing prophylactic or simultaneous CEA + CABG had lower rates of stroke (0%) compared with delayed CEA 1-3 months after CABG (7.7%), without significant perioperative mortality difference. This study included patients with unilateral severe (>70%) asymptomatic carotid stenosis requiring CABG. An earlier partly randomized trial also showed better outcomes for patients undergoing simultaneous procedures (P = 0.045). Interestingly, systematic reviews previously failed to show compelling evidence supporting prophylactic CEA. This could be partly due to the fact that these reviews collectively analyse different cohort qualities. Neurological studies have, however, shown reduced cognitive and phonetic quality and function in patients with unilateral and bilateral asymptomatic carotid artery stenosis. Twenty-one RCTs comparing lone carotid artery stenting (CAS) and CEA informed the American Heart Association guidelines, which declared CAS comparable with CEA for symptomatic and asymptomatic carotid stenosis (CS). However, the risk of death/stroke for CAS alone is double that for CEA alone in the acute phase following onset of symptoms, while CEA alone is associated with a doubled risk of myocardial infarction. There is, however, no significant difference for combined 30-day risk of death/stroke/myocardial infarction. Outcomes of hybrid or simultaneous CAS/CABG procedures show comparable results, albeit from rather small cohorts. While current evidence leans towards simultaneous CEA/CABG, the emergence of hybrid operating theatres in various institutions may allow larger cohorts with subsequent significant data on simultaneous CAS/CABG. A randomized controlled trial comparing both approaches would be crucial in informing future updates of existing guidelines.
INTRODUCTION
A best evidence topic was constructed according to a structured protocol. This protocol is fully described in the ICVTS [1] . 
THREE PART QUESTION

CLINICAL SCENARIO
A 65-year old normally fit and healthy gentleman is referred to you for coronary artery bypass grafting (CABG) following an acute onset of angina and demonstrated severe three-vessel coronary artery disease on angiogram. Preoperative workup reveals bilateral severe asymptomatic carotid artery stenosis. Carotid Doppler documents 60 and 90% stenosis of right and left internal carotid arteries, respectively. He has a positive family history of cerebrovascular accidents (CVAs) and transient ischaemic attacks. He specifically enquires whether he should first get his carotids treated before cardiac surgery or undergo both procedures simultaneously, and what the risk of stroke is for either option. Determined to give him evidence-based advice, you search the literature. The perioperative results in this cohort are similar to those reported in the literature for a simultaneous approach. A meta-analysis by Naylor et al. showed a 6.3% rate of CVA in reversed staged cohort. The authors also show a 92% freedom from neurological events at 10 years. In contrast, the 10-year survival rate is only 62% 
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SEARCH OUTCOME
Six hundred and twenty-four papers were found, of which 25 were deemed to be relevant. These papers are presented in Table 1 .
RESULTS
According to the ESVS guidelines [22] , the incidence of significant carotid stenosis (CS) in patients undergoing CABG ranges between 2.8 and 22% [2, 23] . Of note, 28-40% of patients undergoing carotid endarterectomy (CEA) have significant concomitant coronary artery disease [2, 24] . An individual surgical approach based on specific risk profiles is hitherto recommended.
A randomized controlled trial (RCT) by Illuminati et al. [3] compared simultaneous CEA/CABG with delayed CEA 1-3 months following CABG. They concluded that previous or simultaneous CEA prevents stroke better than delayed CEA without increasing overall surgical risk.
A partly randomized study by Hertzer et al. [2] suggested lower perioperative risk of stroke in patients undergoing combined CEA and CABG compared with CABG alone.
Nwakanma et al. [4] showed that short-and long-term morbidity was not significantly higher for CEA/CABG vs CABG alone.
Santos et al. [5] retrospectively reported a 5% combined risk of death, stroke and MI for staged CEA-CABG within 30 days.
Baiou et al. [6] showed a 5% death rate due to MI and no stroke incidence in patients with significant carotid disease (CD) undergoing CABG without prophylactic CEA. Santos et al. [5] documented similar rates for death and myocardial infraction (MI), and higher stroke rate for delayed CEA-CABG.
Kougias et al. [7] compared patients with unilateral, severe bilateral CD and contralateral carotid occlusion (CO) undergoing CEA/CABG or CABG alone. The risk of stroke or mortality was comparable following CEA/CABG for unilateral and bilateral CD The committee concluded that hybrid revascularization by CAS immediately followed by CABG is a feasible and promising therapeutic strategy that warranted randomized trials. Various RCTs have since been published, most of which included symptomatic patients. The results above by Illuminati et al. [3] , however, had a focus on asymptomatic patients compared with CABG alone. Perioperative stroke and death risk in contralateral CO was higher.
Kolh et al. [8] reported 10-year actuarial event-free rates of MI and stroke following CEA/CABG of 84 and 93%, respectively.
Kaul et al. [9] showed that progression of bilateral (P = 0.007) and intracranial (P = 0.04) CD are predictors of stroke following CEA/CABG.
A systematic review by Naylor et al. [10] showed 4.6% mortality for combined CEA/CABG. The risk of ipsilateral and any stroke after staged CABG-CEA was 5.8 and 6.3%, respectively. Perioperative MI following staged CABG-CEA and CEA-CABG was 0.9 and 6.5%, while combined risk of death/stroke or MI following CEA/CABG and CEA-CABG was 11.5 and 10.2%, respectively.
Levy et al. [11] documented actuarial freedom from neurological events at 10 years of 92 ± 4% for CEA/CABG.
Naylor et al. [12] documented a comparable 30-day risk of death and any stroke for both staged carotid artery stenting (CAS) and CABG, and CEA-CABG.
A meta-analysis by Naylor and Bown [13] on patients with severe asymptomatic bilateral or unilateral CD undergoing CEA/ CABG or CABG alone concluded that whereas there was no compelling evidence supporting prophylactic carotid procedures in patients with unilateral asymptomatic CD, prophylactic CEA or CAS may still be considered for severe bilateral asymptomatic CD in patients requiring CABG.
While Versaci et al. [14] reported a 30-day cumulative incidence of stroke, MI and death of 4% for CAS/CABG, Timaran et al. [15] showed a significantly decreased stroke rate (P < 0.001) compared with CEA/CABG and similar in-hospital death.
Tomai et al. [16] conducted a prospective study of staged or simultaneous CAS and PCI, reporting a death, MI and stroke rate of 4.2, 2.1 and 3.8%, respectively. They concluded that these outcomes compare favourably with previous surgical hybrid experiences, but recommended the strategy for complex patients at high surgical risk.
A single-centre prospective study by Van der Heyden et al. [17] for staged CAS-CABG reported a 12.3% rate of combined death, stroke and MI, while Velissaris et al. [18] reported a 2.2% rate for hybrid CAS/CABG.
CLINICAL BOTTOM LINE
Previous or simultaneous CEA/CABG prevents stroke better than delayed CEA, as shown by a recent randomized study. There is little evidence supporting prophylactic CEA for unilateral asymptomatic, but for severe bilateral asymptomatic CD. Current evidence suggests that outcomes of hybrid CAS/CABG may be comparable with those of simultaneous CEA/CABG.
